dmso dihexa Dimethyl sulfoxide-d6 D 99.9atom , Yes TMS 1 (v/v) 2206-27-1 dihexa resistant to peptidases S46

Constipation affects 11-24% of patients taking these medications, typically developing within the first 4-8 weeks of treatment as the digestive system adjusts to slower motility

Investigated as a research pairing because the two peptides are studied at largely non-overlapping targets, allowing combined exploration of growth-factor and cytoskeletal pathways in the same model

Adherence is the key problem!If 70% of the patient discontinue the treatment after 6-12 month and regain the weight very quickly, handling the adherence weakness is much more helpful to the patient's health than another 3% weight loss.Alma's smart capsule we can probably load GLP1 or Amylin on a once / twice weekly oral dose

Not in human subjects